FitzGerald D - Search Results

1

Immunospecific suppression of encephalitogenic-activated T lymphocytes by chimeric cytotoxin IL-2-PE40.

Beraud E, Lorberboum-Galski H, Chan CC, FitzGerald D, Pastan I, Nussenblatt RB. Beraud E, et al. Among authors: fitzgerald d. Cell Immunol. 1991 Apr 1;133(2):379-89. doi: 10.1016/0008-8749(91)90112-o. Cell Immunol. 1991. PMID: 1707763

2

Targeting growth factor receptors with fusion toxins.

Kreitman RJ, FitzGerald D, Pastan I. Kreitman RJ, et al. Among authors: fitzgerald d. Int J Immunopharmacol. 1992 Apr;14(3):465-72. doi: 10.1016/0192-0561(92)90177-m. Int J Immunopharmacol. 1992. PMID: 1319965 Review.

3

Alanine scanning mutagenesis identifies surface amino acids on domain II of Pseudomonas exotoxin required for cytotoxicity, proper folding, and secretion into periplasm.

Kasturi S, Kihara A, FitzGerald D, Pastan I. Kasturi S, et al. Among authors: fitzgerald d. J Biol Chem. 1992 Nov 15;267(32):23427-33. J Biol Chem. 1992. PMID: 1429683 Free article.

4

In vitro and in vivo suppression of interleukin-2-activated killer cell activity by chimeric proteins between interleukin-2 and Pseudomonas exotoxin.

Puri RK, FitzGerald D, Leland P, Kozak RW, Pastan I. Puri RK, et al. Among authors: fitzgerald d. Cell Immunol. 1992 Sep;143(2):324-34. doi: 10.1016/0008-8749(92)90029-o. Cell Immunol. 1992. PMID: 1511480

5

A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.

Theuer CP, FitzGerald D, Pastan I. Theuer CP, et al. Among authors: fitzgerald d. J Biol Chem. 1992 Aug 25;267(24):16872-7. J Biol Chem. 1992. PMID: 1512230 Free article.

6

Generation of chimeric toxins.

FitzGerald D, Chaudhary VK, Kreitman RJ, Siegall CB, Pastan I. FitzGerald D, et al. Targeted Diagn Ther. 1992;7:447-62. Targeted Diagn Ther. 1992. PMID: 1633306 Review. No abstract available.

7

Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.

Debinski W, Karlsson B, Lindholm L, Siegall CB, Willingham MC, FitzGerald D, Pastan I. Debinski W, et al. Among authors: fitzgerald d. J Clin Invest. 1992 Aug;90(2):405-11. doi: 10.1172/JCI115875. J Clin Invest. 1992. PMID: 1644913 Free PMC article.

8

Substitution of foreign protein sequences into a chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.

Debinski W, Siegall CB, Fitzgerald D, Pastan I. Debinski W, et al. Among authors: fitzgerald d. Mol Cell Biol. 1991 Mar;11(3):1751-3. doi: 10.1128/mcb.11.3.1751-1753.1991. Mol Cell Biol. 1991. PMID: 1671711 Free PMC article.

9

Recombinant toxins for cancer treatment.

Pastan I, FitzGerald D. Pastan I, et al. Among authors: fitzgerald d. Science. 1991 Nov 22;254(5035):1173-7. doi: 10.1126/science.1683495. Science. 1991. PMID: 1683495 Review.

10

Analysis of Pseudomonas exotoxin activation and conformational changes by using monoclonal antibodies as probes.

Ogata M, Pastan I, FitzGerald D. Ogata M, et al. Among authors: fitzgerald d. Infect Immun. 1991 Jan;59(1):407-14. doi: 10.1128/iai.59.1.407-414.1991. Infect Immun. 1991. PMID: 1702764 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,829 results

Search Page

Filters